Navigation Links
Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
Date:5/31/2013

HAYWARD, Calif., May 31, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex , President and Chief Executive Officer, and Dr. Colin Hislop , Senior Vice President and Chief Medical Officer, will present a corporate update at the 2013 Annual Jefferies Global Healthcare Conference.

Anthera will present on at 1:30PM ET, June 6th in Ballroom 1 of the Grand Hyatt Hotel in New York City.

About Blisibimod and PEARL-SC

Anthera is developing blisibimod, a selective inhibitor of B-cell activating factor (BAFF), to explore its clinical utility in various autoimmune diseases including systemic lupus erythematosus (SLE) and IgA nephropathy. Blisibimod is a novel fusion protein, or peptibody, and is distinct from an antibody. Anthera owns worldwide rights to blisibimod in all potential indications. BAFF, also known as BLyS (B lymphocyte stimulator), is a tumor necrosis family member and is critical to the development, maintenance and survival of B-cells. B-cells represent a critical component of human immune response to infection and other pathogens.  However, abnormal elevations of B-cells and BAFF may lead to an overactive immune response which may damage normal healthy tissues and organ systems. Multiple clinical studies with BAFF antagonists have reported the potential benefit of BAFF inhibitors in treating patients with lupus and rheumatoid arthritis.

In April 2012, Anthera completed the PEARL-SC Phase 2b clinical study to evaluate the efficacy and safety of subcutaneous blisibimod in patients with active and seropositive lupus. In June and July of 2012 Anthera announced results fro
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
2. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
3. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
4. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
5. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
6. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
7. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
8. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
9. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
10. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
11. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Global Markets ... -- Focus on End Users ... A drug delivery system is ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... PDII ), today reported financial and operational results ... Summary financial and operating highlights include: Full year ... 2011 and 2010 revenue excludes the company,s Pharmakon business unit, ... in discontinued operations. Full year 2011 operating loss of $4.7 ...
... March 7, 2012  The Starkey Hearing Foundation Israel-Palestine Hearing ... Palestinians together for a common cause to address a ... a year, Starkey Hearing Foundation, which strives to change ... visited the region in an effort to promote greater ...
Cached Medicine Technology:PDI Reports 2011 Fourth Quarter and Year End Financial Results 2PDI Reports 2011 Fourth Quarter and Year End Financial Results 3PDI Reports 2011 Fourth Quarter and Year End Financial Results 4PDI Reports 2011 Fourth Quarter and Year End Financial Results 5PDI Reports 2011 Fourth Quarter and Year End Financial Results 6PDI Reports 2011 Fourth Quarter and Year End Financial Results 7PDI Reports 2011 Fourth Quarter and Year End Financial Results 8PDI Reports 2011 Fourth Quarter and Year End Financial Results 9PDI Reports 2011 Fourth Quarter and Year End Financial Results 10Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 2Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 3Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 4Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 5
(Date:7/9/2014)... the most common type of lung cancer, researchers have ... role in forming tumors. The new knowledge may expand ... genetic changes already are available or are in clinical ... investigators from The Cancer Genome Atlas (TCGA), including researchers ... Harvard Medical School and other institutions, studied tumors from ...
(Date:7/9/2014)... -- Researchers from The Miriam Hospital have found ... who are also depressed have difficulty sticking to ... particularly true for women, and screening and brief ... of treatment. The study and its findings are ... , Chronic obstructive pulmonary disease is a ...
(Date:7/9/2014)... have been linked to an emerging fungal disease ... Institute for Mathematical and Biological Synthesis (NIMBioS) shows ... , In a series of mathematical models, researchers ... internal organs in frogs, could cause extinction of ... exposed to the virus every few years, a ...
(Date:7/9/2014)... (July 9, 2014) A retrospective study conducted by ... colleagues reports that among adults with intellectual and developmental ... number of years receiving dental care increased. The findings, ... in Dentistry , may help improve interventions designed to ... , The researchers reviewed the dental records of ...
(Date:7/9/2014)... risen dramatically in Western societies. One frequently cited reason ... have fewer infections than previous generations, thereby delaying maturation ... at Sahlgrenska Academy, University of Gothenburg, monitored children until ... immune system in relation to allergic disease. All of ... Gtaland Region, half of them on farms that produced ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3
... of enzyme involved in cancer, aging , , MONDAY, Sept. ... of the active region of telomerase, an enzyme involved ... by adding repeats of a short DNA sequence to ... to prevent damage and loss of genetic information during ...
... different times of year suggest that the actions of ... by season, according to a report in the September ... of the JAMA/Archives journals. These fluctuations may potentially explain ... is a common experience in temperate zones that individuals ...
... many calories per minute playing an active video game ... is also significantly higher with the active game, according ... Archives of Pediatrics & Adolescent Medicine , one of ... rapidly becoming the preferred leisure-time activity for school-aged children, ...
... ... World Vision,s emergency supplies ready in Mississippi, Dallas; more on ... "on the frontlines" helping vulnerable, ... low-income families, SEATTLE, Sept. 1 As Hurricane Gustav lashes,Louisiana and ...
... Study found it predicted outcome months after patient went ... patients who sleep during the day while in rehabilitation ... the study, which was expected to be published in ... tracked the sleeping patterns and other predictors of recovery ...
... As baby boomers age, varicose,veins can signal health ... ulcers that can be a harbinger of a ... laser surgery exists that can,reduce the risk of ... to the rising demand for vein corrective,procedures, an ...
Cached Medicine News:Health News:Secrets of Telomerase Revealed 2Health News:PET scans help identify mechanism underlying seasonal mood changes 2Health News:Children's calorie expenditure, heart rate increase during active video games 2Health News:Children's calorie expenditure, heart rate increase during active video games 3Health News:Gustav: World Vision Teams Assist Evacuees in Jackson and Dallas, Prepare Response 2Health News:Gustav: World Vision Teams Assist Evacuees in Jackson and Dallas, Prepare Response 3Health News:Daytime Sleeping Linked to Poor Recovery in Older Patients 2Health News:Venous Surgery EMR: SonoSoft Chooses Practice Management Solution MPMsoft as its Medical Billing Software 2
... medical record the development of which began ... comprehensive electronic medical record designed to be ... point of care and to be shared ... Internet. AmkaiCharts chronicles patient history, encounters, medication ...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes...
... applanation tonometer is designed to fit ... or most "Zeiss" style models. This ... intra-ocular pressure readings. The instrument stays ... and the prism is swung down ...
... third-generation immunoassay system combines continuous ... processing with a broad testing ... higher volume clinical laboratories to ... tests simultaneously, as well as ...
Medicine Products: